Precision Dosing of Rapid-Acting Insulin Matters
Authors:
- 27 April 2020
- journal article
- review article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 22 (5) , 346-351
Abstract
Despite several molecular and technological advances in insulin therapy and insulin delivery, global evidence highlights inadequate glycemic control in populations with type 1 diabetes (T1D) and type 2 diabetes (T2D). In this review, we discuss the importance of more precise dosing of insulin as one of the approaches to improve glycemic control while reducing hypoglycemic events. This report is based on the expert opinion of authors and literature search of articles relevant to the past and present insulin delivery devices in diabetes management, especially half-unit insulin pens. We describe the various factors that facilitate better glycemic control, focusing on the impact of appropriate insulin delivery device selection on diabetes management. Precision dosing of insulin is a lesser-studied factor that contributes toward better glycemic control. Insulin pens have consistently outperformed syringes as delivery devices due to their greater accuracy and precision of dosing, ease-of-use, and patient preference. These advantages make them better suited to administer insulin in hypoglycemia-prone insulin-sensitive people with T1D, particularly younger children and geriatric patients. Half-unit insulin pens further extend this benefit by delivering half-unit doses of insulin accurately. They may contribute to better management of diabetes by allowing flexible dosing for mealtimes and physical activities even in erratic diet situations or illnesses by offering corrective doses in small increments. They are ideal delivery devices for insulin-sensitive people with T1D who require greater accuracy and precision in insulin delivery to achieve more stringent glycemic control.Keywords
This publication has 48 references indexed in Scilit:
- Insulin Therapy in Type 2 Diabetes MellitusEndocrinology and Metabolism Clinics of North America, 2012
- Dose accuracy and durability of a durable insulin pen before and after simulated lifetime useCurrent Medical Research and Opinion, 2011
- Managing diabetes-related costs and quality of life issues: Value of insulin analogs and pens for inpatient useHealth Policy, 2010
- A Review of Insulin Pen DevicesPostgraduate Medicine, 2010
- Improvement in health‐related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patientsJournal of Evaluation in Clinical Practice, 2009
- Good glycemic control remains crucial in prevention of late diabetic complications - the Linköping Diabetes Complications StudyPediatric Diabetes, 2009
- Should minimal blood glucose variability become the gold standard of glycemic control?Journal of Diabetes and its Complications, 2005
- Accuracy and Precision of Low-Dose Insulin Administration Using Syringes, Pen Injectors, and a PumpClinical Pediatrics, 2004
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Epidemiology of severe hypoglycemia in the diabetes control and complications trialThe American Journal of Medicine, 1991